Cargando…

BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina

In Ashkenazi Jewish (AJ) high risk families 3 mutations [2 in BRCA1 (c. 68_69del and c.5266dup) and 1 in BRCA2 (c.5946del)] account for the majority of high risk breast and ovarian cancer cases in that ethnic group. Few studies with limited number of genotyped individuals have expanded the spectrum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solano, Angela R., Liria, Natalia C., Jalil, Fernanda S., Faggionato, Daniela M., Mele, Pablo G., Mampel, Alejandra, Cardoso, Florencia C., Podesta, Ernesto J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113569/ https://www.ncbi.nlm.nih.gov/pubmed/30186769 http://dx.doi.org/10.3389/fonc.2018.00323

Ejemplares similares

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
por: Hamel, Nancy, et al.
Publicado: (2003)

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry
por: Tennen, Ruth I., et al.
Publicado: (2020)

Study of the Genetic Variants in BRCA1/2 and Non-BRCA Genes in a Population-Based Cohort of 2155 Breast/Ovary Cancer Patients, Including 443 Triple-Negative Breast Cancer Patients, in Argentina
por: Solano, Angela R., et al.
Publicado: (2021)

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
por: Chen-Shtoyerman, R, et al.
Publicado: (2001)

BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population
por: Cardoso, Florencia C., et al.
Publicado: (2018)

Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial
por: Manchanda, Ranjit, et al.
Publicado: (2014)

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
por: Vazina, A, et al.
Publicado: (2000)

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)
por: Apicella, Carmel, et al.
Publicado: (2003)

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations
por: Greenwood, Celia MT, et al.
Publicado: (2010)

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
por: Lehrer, S., et al.
Publicado: (1998)

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
por: Manchanda, Ranjit, et al.
Publicado: (2014)

Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil
por: Dillenburg, Crisle Vignol, et al.
Publicado: (2012)

Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations
por: Cox, Devin M., et al.
Publicado: (2018)

Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women
por: Hardy, Melanie W., et al.
Publicado: (2022)

Carrier screening in individuals of Ashkenazi Jewish descent
por: Gross, Susan J., et al.
Publicado: (2008)

Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients
por: Díez, O, et al.
Publicado: (1999)

Genetic architecture of prostate cancer in the Ashkenazi Jewish population
por: Vijai, J, et al.
Publicado: (2011)

High mammographic density in women of Ashkenazi Jewish descent
por: Caswell, Jennifer L, et al.
Publicado: (2013)

The time and place of European admixture in Ashkenazi Jewish history
por: Xue, James, et al.
Publicado: (2017)

Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants
por: Castillo, Cecilia, et al.
Publicado: (2022)

Beyond the “Jewish panel”: the importance of offering expanded carrier screening to the Ashkenazi Jewish population
por: Dolitsky, Shelley, et al.
Publicado: (2020)

The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel
por: Figer, A, et al.
Publicado: (2001)

Implications for health and disease in the genetic signature of the Ashkenazi Jewish population
por: Guha, Saurav, et al.
Publicado: (2012)

Case report: BRCA in the Ashkenazi population: are current testing guidelines too exclusive?
por: Saunders, Katherine H, et al.
Publicado: (2011)

Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper
por: Cousens, Nicole E, et al.
Publicado: (2021)

Genetic Complexity of Crohn’s Disease in Two Large Ashkenazi Jewish Families
por: Levine, Adam P., et al.
Publicado: (2016)

Prevalence of Germline BRCA1/2 Variants in Ashkenazi and Non-Ashkenazi Prostate Cancer Populations: A Systematic Review and Meta-Analysis
por: Cioffi, Antonio, et al.
Publicado: (2023)

Founder BRCA1 mutations in Nepalese population
por: Mehta, Anurag, et al.
Publicado: (2022)

Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population
por: Rivas, Manuel A., et al.
Publicado: (2018)

Ashkenazi Jewish Centenarians Do Not Demonstrate Enrichment in Mitochondrial Haplogroup J
por: Shlush, Liran I., et al.
Publicado: (2008)

Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk
por: Hamada, Tsuyoshi, et al.
Publicado: (2019)

Evidence of a founder BRCA1 mutation in Scotland
por: Liede, A, et al.
Publicado: (2000)

Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico
por: Díaz-Velásquez, Clara Estela, et al.
Publicado: (2023)

Identification of a founder BRCA2 mutation in Sardinia
por: Pisano, M, et al.
Publicado: (2000)

BRCA1 and BRCA2 screening of nine Chilean founder mutations through allelic-discrimination and real-time PCR in breast/ovarian cancer patients
por: Alvarez, Carolina, et al.
Publicado: (2022)

Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population
por: Rivas, Manuel A., et al.
Publicado: (2019)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry
por: Wang, Zhaoming, et al.
Publicado: (2012)

Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure
por: Ungar, Bella, et al.
Publicado: (2015)

A collaborative genetic carrier screening model for the British Ashkenazi Jewish community
por: Ziff, Monica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hc0jb1l81181po5va5ifk83mcs